91 related articles for article (PubMed ID: 8643882)
1. Global tests for combination drug studies in factorial trials.
Hung HM
Stat Med; 1996 Feb; 15(3):233-47. PubMed ID: 8643882
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a combination drug with multiple doses in unbalanced factorial design clinical trials.
Hung HM
Stat Med; 2000 Aug; 19(16):2079-87. PubMed ID: 10931512
[TBL] [Abstract][Full Text] [Related]
3. Large sample tests for binary outcomes in fixed-dose combination drug studies.
Wang SJ; Hung HM
Biometrics; 1997 Jun; 53(2):498-503. PubMed ID: 9192448
[TBL] [Abstract][Full Text] [Related]
4. Testing for the existence of a desirable dose combination.
Hung HM; Chi GY; Lipicky RJ
Biometrics; 1993 Mar; 49(1):85-94. PubMed ID: 8513112
[TBL] [Abstract][Full Text] [Related]
5. [Fixed-dose combinations in antihypertensive treatment: is it necessary to examine the effectiveness of each component?].
Dechend R; Derer W; Müller DN
MMW Fortschr Med; 2009 Nov; 151(45):46-7. PubMed ID: 19960726
[No Abstract] [Full Text] [Related]
6. Large sample tests for simultaneous comparison to multiple controls in terms of binomial proportions.
Soulakova JN; Luo L
J Biopharm Stat; 2013 May; 23(3):589-603. PubMed ID: 23611197
[TBL] [Abstract][Full Text] [Related]
7. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.
Papademetriou V; Hainer JW; Sugg J; Munzer D;
Am J Hypertens; 2006 Dec; 19(12):1217-25. PubMed ID: 17161766
[TBL] [Abstract][Full Text] [Related]
8. Fallback tests in dose-response clinical trials.
Dmitrienko A; Wiens B; Westfall P
J Biopharm Stat; 2006; 16(5):745-55. PubMed ID: 17037269
[TBL] [Abstract][Full Text] [Related]
9. Outcomes from treatment. Clinical applications from recent trials.
Howes LG
Aust Fam Physician; 1999 Jul; 28(7):707-10. PubMed ID: 10431429
[TBL] [Abstract][Full Text] [Related]
10. Strategies for analyzing multilevel cluster-randomized studies with binary outcomes collected at varying intervals of time.
Olsen MK; DeLong ER; Oddone EZ; Bosworth HB
Stat Med; 2008 Dec; 27(29):6055-71. PubMed ID: 18825655
[TBL] [Abstract][Full Text] [Related]
11. Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration.
J Hypertens; 1998 Feb; 16(2):127-37. PubMed ID: 9535138
[TBL] [Abstract][Full Text] [Related]
12. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
Leenen FH
Can J Cardiol; 2004 Aug; 20 Suppl B():77B-82B. PubMed ID: 15309209
[TBL] [Abstract][Full Text] [Related]
13. Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: the first randomized controlled trial to compare the clinical outcome effects of first-line combination therapies in hypertension.
Jamerson KA; Bakris GL; Wun CC; Dahlöf B; Lefkowitz M; Manfreda S; Pitt B; Velazquez EJ; Weber MA
Am J Hypertens; 2004 Sep; 17(9):793-801. PubMed ID: 15363822
[TBL] [Abstract][Full Text] [Related]
14. The analysis of a multiple-dose, combination-drug clinical trial using response surface methodology.
Phillips JA; Cairns V; Koch GG
J Biopharm Stat; 1992; 2(1):49-67. PubMed ID: 1300205
[TBL] [Abstract][Full Text] [Related]
15. Comparison of several testing strategies for combination drug efficacy trials based on the closure principle.
Soulakova JN
Stat Med; 2009 Jan; 28(2):260-73. PubMed ID: 18991315
[TBL] [Abstract][Full Text] [Related]
16. Resampling in multiple-dose factorial designs.
Frommolt P; Hellmich M
Biom J; 2009 Dec; 51(6):915-31. PubMed ID: 20029896
[TBL] [Abstract][Full Text] [Related]
17. Parametric versus non-parametric statistics in the analysis of randomized trials with non-normally distributed data.
Vickers AJ
BMC Med Res Methodol; 2005 Nov; 5():35. PubMed ID: 16269081
[TBL] [Abstract][Full Text] [Related]
18. Permutation test following covariate-adaptive randomization in randomized controlled trials.
Hasegawa T; Tango T
J Biopharm Stat; 2009; 19(1):106-19. PubMed ID: 19127470
[TBL] [Abstract][Full Text] [Related]
19. Order-restricted tests for stratified comparisons of binomial proportions.
Agresti A; Coull BA
Biometrics; 1996 Sep; 52(3):1103-11. PubMed ID: 8805770
[TBL] [Abstract][Full Text] [Related]
20. Average bioequivalence for two-sequence two-period crossover design with incomplete data.
Lee JY; Kim BC; Park SG
J Biopharm Stat; 2005; 15(5):857-67. PubMed ID: 16078389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
